Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Bath & Body Works, Inc.
Report date May 14, 2020 · Filed May 18, 2020
Section 16 reporting ended · disclosed 2020-05-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.50 par valueSEC Table I · non-derivative | Direct | 50,038.05 |
Reported balance
After 2020-05-14 transaction · row 1
1 source rowRow 1 · 2020-05-14 · Grant · Acquired 3,629 · Balance 50,038.05 |
| Common Stock, $0.50 par valueSEC Table I · non-derivative | IndirectBy Investment Corporation | 3,693 |
Reported balance
Holding disclosure · report date 2020-05-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,693 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2020 Filed May 18, 2020 22:51 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantCommon Stock, $0.50 par value | 3,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-007981 · doc4.xml · nonDerivative · entry 1 ZIMMERMAN RAYMOND · CIK 0000918909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,038.05 Read SEC document |
| March 28, 2019 Filed Aug 7, 2019 20:01 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantCommon Stock, $0.50 par value | 4,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-010963 · doc4.xml · nonDerivative · entry 1 ZIMMERMAN RAYMOND · CIK 0000918909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,716 Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 23:17 UTC | Bath & Body Works, Inc. LB · Entity 4091 | SaleCommon Stock, $0.50 par value | 6,385 | $28.33 | $180,877.47 |
DisclosureSEC source: 0001225208-18-015872 · doc4.xml · nonDerivative · entry 1 ZIMMERMAN RAYMOND · CIK 0000918909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,693 F1 · price: Price represents a weighted average of the sale price. Shares were sold at prices ranging from $28.24 to $28.68. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price. F2 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 20:47 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantCommon Stock, $0.50 par value | 3,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006643 · doc4.xml · nonDerivative · entry 1 ZIMMERMAN RAYMOND · CIK 0000918909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,861 Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:39 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantCommon Stock, $0.50 par value | 2,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-007423 · doc4.xml · nonDerivative · entry 1 ZIMMERMAN RAYMOND · CIK 0000918909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,609 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.